Myeloma News and Research

RSS
NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

Research explores relationship between personal history of infectious fever and cancer risk

Research explores relationship between personal history of infectious fever and cancer risk

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

NUS scientists develop new technology to customize optimal drug ‘cocktail’ for myeloma patients

FOXM1 contributes to treatment failure in acute myeloid leukemia

FOXM1 contributes to treatment failure in acute myeloid leukemia

New discovery could pave way for improved leukemia treatment

New discovery could pave way for improved leukemia treatment

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

RNA and DNA sequencing platform matches broader swath of drugs to late-stage cancer patients

Research uncovers new approach for expanding stem cells from umbilical cord blood

Research uncovers new approach for expanding stem cells from umbilical cord blood

Scientists solve 60-year-old mystery of how thalidomide caused birth defects

Scientists solve 60-year-old mystery of how thalidomide caused birth defects

Researchers discover new antibodies that have capacity to treat all Ebola viruses

Researchers discover new antibodies that have capacity to treat all Ebola viruses

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Janssen’s Darzalex receives positive CHMP opinion for treating multiple myeloma patients

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

Survey: Blood cancers still take longer time for diagnosis than other types of cancer

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

New study suggests testing urine and blood serum as better way to diagnose myeloma

New study suggests testing urine and blood serum as better way to diagnose myeloma

Researchers use x-ray crystallography to reveal how curcumin inhibits cancer

Researchers use x-ray crystallography to reveal how curcumin inhibits cancer

Drug used in stem cell therapy may protect against smoke-induced lung injury

Drug used in stem cell therapy may protect against smoke-induced lung injury

Streamlining and translating basic science discoveries into the clinic

Streamlining and translating basic science discoveries into the clinic

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA